Acer has been keen on making deployments in the smart medical care, antibacterial and eco-friendly product sectors in the wake of the COVID-19 pandemic, according to company chairman and CEO Jason Chen.
Chen pointed out that Acer has been actively seeking approvals for its medical care and AI solutions from food and drug authorities and has already obtained four certificates: one for telemedicine and one for AI-enabled eyecare in Taiwan; and one each in Thailand and Indonesia for selling medical materials.
Acer Healthcare, a subsidiary of Acer, has obtained a license for its VeriSee DR, AI-assisted solutions for Diabetic Retinopathy (DR) identification, in Indonesia. The solutions have already been adopted by five medical centers and several major clinics in Taiwan.
Acer is also rolling out IT products such as monitors, notebooks, keyboards and mice that are made with antibacterial materials, targeting users from the medical care industry. The company's subsidiary GadgeTek has also released antibacterial clothing.
Acer has recently joined the RE100 initiative seeking to fully use renewable energy by 2035. It has also released Aspire Vero notebook that is made by recycled materials.
For regular IT products, Chen pointed out that Acer sold over 100,000 notebooks during Amazon's Prime Day promotion campaign in 2021, more than double the volumes in the event in 2020.
To ease the impact from the slow shipment processing at ports worldwide, Acer has shifted some of its shipments for the US to air transportation, and is turning to railroad transportation for products shipped to Europe, said Chen.
